Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.61 |
| ▸ | CYP11B2 | P19099 | 7/20 | 0.61 |
| ▸ | TNF | P01375 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 4/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | APAF1 | O14727 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL230355 | 0.94 | TDP1 (0.63) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL229631 | 0.93 | TDP1 (0.61) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL2380384 | 0.91 | TDP1 (0.65) | TDP1CYP11B1CYP11B2TNFHTT | |
| Benzimidazole SCHEMBL10434506 | 0.85 | TDP1 (0.53) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL9450146 | 0.85 | TDP1 (0.62) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL230330 | 0.84 | TDP1 (0.78) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL6794361 | 0.83 | TDP1 (0.76) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL6442808 | 0.83 | TDP1 (1.00) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL30564238 | 0.83 | TDP1 (0.76) | TDP1CYP11B1CYP11B2TNFHTT | |
| Bromide SCHEMBL10912945 | 0.82 | TDP1 (0.75) | TDP1CYP11B1CYP11B2TNFHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250361280-A1 | CONJUGATED HEPCIDIN MIMETICS | PROTAGONIST THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | claimed |
| CN-116606290-B | Method for efficiently catalyzing and synthesizing fluorine-containing polypeptide condensing agent by adopting green acid binding agent | 浙江大学 | 2024-11-01 | — | — | CN | claimed |
| CN-115832607-B | Preparation method of battery diaphragm, battery diaphragm and secondary battery | 宁德时代新能源科技股份有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-116606290-A | Method for efficiently catalyzing and synthesizing fluorine-containing polypeptide condensing agent by adopting green acid binding agent | 浙江大学 | 2023-08-18 | — | — | CN | claimed |
| CN-115832607-A | Preparation method of battery diaphragm, battery diaphragm and secondary battery | 宁德时代新能源科技股份有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-107880079-B | Cyclic N-heterocyclic bis-carbene-palladium complex and preparation method and application thereof | 天津师范大学 | 2020-05-08 | — | — | CN | claimed |
| EP-1984968-B1 | IONIC LIQUID ELECTROLYTE | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2017-04-05 | — | — | EP | claimed |
| EP-2419551-A2 | ELECTROLYTE AND SURFACE-ACTIVE ADDITIVES FOR THE GALVANIC DEPOSITION OF SMOOTH, DENSE ALUMINUM LAYERS FROM IONIC LIQUIDS | BASF SE (DE) | 2012-02-22 | — | — | EP | claimed |
| US-20120006688-A1 | ELECTROLYTE AND SURFACE-ACTIVE ADDITIVES FOR THE ELECTROCHEMICAL DEPOSITION OF SMOOTH, DENSE ALUMINUM LAYERS FROM IONIC LIQUIDS | BASF SE (DE) | 2012-01-12 | — | — | US | claimed |
| US-20120001134-A1 | LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS | PLEOTINT, LLC (US) | 2012-01-05 | — | — | US | claimed |
| WO-2010106072-A2 | ELECTROLYTE AND SURFACE-ACTIVE ADDITIVES FOR THE GALVANIC DEPOSITION OF SMOOTH, DENSE ALUMINUM LAYERS FROM IONIC LIQUIDS | BASF SE (DE) | 2010-09-23 | — | — | WO | claimed |
| US-20090283728-A1 | LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS | PLEOTINT, LLC (US) | 2009-11-19 | — | — | US | claimed |
| EP-2082005-A1 | LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS | Pleotint, L.L.C. (US) | 2009-07-29 | — | — | EP | claimed |
| US-20080100902-A1 | LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS | PLEOTINT, LLC (US) | 2008-05-01 | — | — | US | claimed |
| WO-2008028128-A1 | LIGAND EXCHANGE THERMOCHROMIC, (LETC), SYSTEMS | PLEOTINT, L.L.C. (US) | 2008-03-06 | — | — | WO | claimed |
| US-5441563-A | Antifoam agents in printing inks | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1995-08-15 | — | — | US | claimed |
| EP-0271260-B1 | Supersensitization of silver halide emulsions | MINNESOTA MINING & MFG (US) | 1995-01-04 | — | — | EP | claimed |
| US-4873184-A | ADDITION OF A METAL COMPLEXING AGENT TO THE EMULSION; HIGH SPEED | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-10-10 | — | — | US | claimed |
| EP-0271260-A2 | Supersensitization of silver halide emulsions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-06-15 | — | — | EP | claimed |
| US-4662905-A | REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE | Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) | 1987-05-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361280-A1 | CONJUGATED HEPCIDIN MIMETICS | HAMP, VIP, HDGF | TDP1 4878/4885CYP11B1 971/4885CYP11B2 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.